{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:36:19Z","timestamp":1779917779059,"version":"3.53.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijpddr.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T03:23:25Z","timestamp":1603769005000},"page":"208-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-2007","authenticated-orcid":false,"given":"Sean T.","family":"Windle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4352-0562","authenticated-orcid":false,"given":"Kristin D.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla B.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-8389","authenticated-orcid":false,"given":"Jianbing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramoncito L.","family":"Caleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-9312","authenticated-orcid":false,"given":"Rifat S.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-8454","authenticated-orcid":false,"given":"Thomas E.","family":"Wellems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.10.009_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpddr.2015.05.005","article-title":"Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya","volume":"5","author":"Achieng","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00759-17","article-title":"Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in the Gambia","volume":"61","author":"Amambua-Ngwa","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib4","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/AAC.02902-14","article-title":"Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay","volume":"58","author":"Amaratunga","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jir486","article-title":"Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda","volume":"204","author":"Baliraine","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib82","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.03647-14","article-title":"In vivo selection of Plasmodium falciparum pfcrt and pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso","volume":"59","author":"Baraka","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib7","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1128\/AAC.42.9.2347","article-title":"In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaound\u00e9, Cameroon","volume":"42","author":"Basco","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4269\/ajtmh.2007.76.20","article-title":"Molecular epidemiology of malaria in Cameroon. XXIV. Trends of in vitro antimalarial drug responses in Yaounde, Cameroon","volume":"76","author":"Basco","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature11867","article-title":"Finding the sources of missing heritability in a yeast cross","volume":"494","author":"Bloom","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/bioinformatics\/btg112","article-title":"R\/qtl: QTL mapping in experimental crosses","volume":"19","author":"Broman","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41467-017-01352-3","article-title":"Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling","volume":"8","author":"Challenger","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib13","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1128\/AAC.02838-15","article-title":"The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites","volume":"60","author":"Chavchich","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/infdis\/jiu141","article-title":"Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children","volume":"210","author":"Conrad","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/mol.61.1.35","article-title":"Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum","volume":"61","author":"Cooper","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1083\/jcb.113.5.1033","article-title":"A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole","volume":"113","author":"Cowman","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0035-9203(97)90110-3","article-title":"An alternative to serum for cultivation of Plasmodium falciparum in vitro","volume":"91","author":"Cranmer","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12936-017-1700-8","article-title":"Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali","volume":"16","author":"Dama","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrmicro3450","article-title":"Advances in molecular genetic systems in malaria","volume":"13","author":"de Koning-Ward","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib21","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","article-title":"Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02731-18","article-title":"Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness","volume":"10","author":"Dhingra","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/AAC.50.5.1893-1895.2006","article-title":"Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic","volume":"50","author":"Dokomajilar","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-2958.2000.01914.x","article-title":"Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum","volume":"36","author":"Duraisingh","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064299","article-title":"The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011","volume":"8","author":"Eyase","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1475-2875-11-176","article-title":"Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania","volume":"11","author":"Farnert","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12936-018-2210-z","article-title":"A set of microsatellite markers to differentiate Plasmodium falciparum progeny of four genetic crosses","volume":"17","author":"Figan","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/345255a0","article-title":"Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum","volume":"345","author":"Foote","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib30","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/AAC.05102-11","article-title":"Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine","volume":"55","author":"Gadalla","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1101\/gr.255505.119","article-title":"Detection of simple and complex de novo mutations with multiple reference sequences","volume":"30","author":"Garimella","year":"2020","journal-title":"Genome Res."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1128\/AAC.00968-08","article-title":"Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria","volume":"53","author":"Happi","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib33","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1038\/s41467-020-18624-0","article-title":"Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility","volume":"11","author":"Harding","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","volume":"51","author":"Humphreys","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib37","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1073\/pnas.1804492115","article-title":"Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors","volume":"115","author":"Lane","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.meegid.2011.01.003","article-title":"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine","volume":"11","author":"Lekana-Douki","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1179\/2047773214Y.0000000158","article-title":"High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea","volume":"108","author":"Li","year":"2014","journal-title":"Pathog. Glob. Health"},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2020.10.009_bib40","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","article-title":"The clinical efficacy of artemether\/lumefantrine (Coartem)","volume":"8","author":"Makanga","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"Malmberg","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1235264","article-title":"The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system","volume":"340","author":"Molina-Cruz","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib43","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.00638-09","article-title":"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","volume":"53","author":"Mwai","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/molbev\/msl185","article-title":"Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites","volume":"24","author":"Nair","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2011.05.002","article-title":"Malaria parasite clag3 genes determine channel-mediated nutrient uptake by infected red blood cells","volume":"145","author":"Nguitragool","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.01412-09","article-title":"In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda","volume":"54","author":"Nsobya","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib47","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/jac\/dks252","article-title":"Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine","volume":"67","author":"Nzila","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0035-9203(93)90434-R","article-title":"Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria","volume":"87","author":"Oduola","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpddr.2014.07.003","article-title":"Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya","volume":"4","author":"Okombo","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib50","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1073\/pnas.87.8.3018","article-title":"Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria","volume":"87","author":"Peterson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib51","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003-2013): the role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib54","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/JCM.00623-06","article-title":"Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo","volume":"44","author":"Pradines","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.43.2.418","article-title":"In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs","volume":"43","author":"Pradines","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2020.10.009_bib56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1475-2875-8-S1-S3","article-title":"Coartem: the journey to the clinic","volume":"8","author":"Premji","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib57","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"Price","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib58","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.1813386115","article-title":"Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model","volume":"115","author":"S\u00e1","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib59","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41467-019-12256-9","article-title":"Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross","volume":"10","author":"S\u00e1","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib60","doi-asserted-by":"crossref","first-page":"18883","DOI":"10.1073\/pnas.0911317106","article-title":"Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine","volume":"106","author":"S\u00e1","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib62","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","article-title":"The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa","volume":"12","author":"Sisowath","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/596738","article-title":"In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa","volume":"199","author":"Sisowath","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib64","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sisowath","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib65","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib66","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso","volume":"54","author":"Som\u00e9","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sonden","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of pfcrt and pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4269\/ajtmh.2012.11-0182","article-title":"Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine","volume":"86","author":"Valecha","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nmeth.3432","article-title":"Plasmodium falciparum genetic crosses in a humanized mouse model","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib71","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib72","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pt.2020.07.009","article-title":"Humanized mice and the rebirth of malaria genetic crosses","volume":"36","author":"Vendrely","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib74","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","article-title":"Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization","volume":"23","author":"Wang","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib75","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1073\/pnas.88.8.3382","article-title":"Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7","volume":"88","author":"Wellems","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib77","series-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib78","series-title":"World Malaria Report 2019","year":"2019"},{"key":"10.1016\/j.ijpddr.2020.10.009_bib83","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib80","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijpddr.2020.10.009_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(07)60236-0","article-title":"Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial","volume":"369","author":"Zongo","year":"2007","journal-title":"Lancet"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:53:03Z","timestamp":1761922383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":80,"alternative-id":["S2211320720300403"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.10.009","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}